Patient Guide: Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 51 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04379050
Status: ACTIVE_NOT_RECRUITING
Condition: Parkinson's Disease (PD)
Phase: PHASE3

Where You Can Participate

This study is available at 51 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Sun City, Arizona
  • • Aurora, Colorado
  • • And 48 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease - Join Clinical Trial NCTNCT04379050

How to Join This Clinical Trial - NCTNCT04379050

Learn how to participate in this PHASE3 trial studying an investigational therapy for Parkinson's Disease (PD). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Parkinson's Disease (PD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Parkinson's Disease (PD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04379050 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 51 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: Contact for availability

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33486 - United States

Status: Contact for availability

Clinical Research Site

Indianapolis, Indiana 46202 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

Lebanon, New Hampshire 03756 - United States

Status: Contact for availability

Clinical Research Site

Raleigh, North Carolina 27612-8106 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97232-2003 - United States

Status: Contact for availability

And 41 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Parkinson's Disease (PD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships